Amarin Corp. Plc (AMRN)

17.32
0.49 2.91
NASDAQ : Health Technology
Prev Close 16.83
Open 16.95
Day Low/High 16.78 / 17.42
52 Wk Low/High 2.35 / 23.34
Volume 4.48M
Avg Volume 7.23M
Exchange NASDAQ
Shares Outstanding 330.64M
Market Cap 5.88B
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ollie's Bargain Outlet, Novo Nordisk, Avnet: 'Mad Money' Lightning Round

Ollie's Bargain Outlet, Novo Nordisk, Avnet: 'Mad Money' Lightning Round

Jim Cramer weighs in on Ollie's Bargain Outlet, Novo Nordisk, Avnet, Cabot Corp., Helmerich & Payne, Amarin, Golar LNG, Nio and more.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amarin Corporation ("Amarin" or the "Company")(NASDAQ:AMRN) of the April 23, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has...

I Have My Eye on This Warren Buffett Stock Amid the Choppy Action

I Have My Eye on This Warren Buffett Stock Amid the Choppy Action

Market players are more skeptical of the quick moves on U.S.-China trade news.

Lyft's Aggressive IPO Pricing Was a Mistake

Lyft's Aggressive IPO Pricing Was a Mistake

Poor trading action in Lyft will likely create some distrust of upcoming IPOs, and Uber in particular.

The Best Approach to Trading Lyft

The Best Approach to Trading Lyft

Valuation and all the other issues that are being discussed are secondary to the price action.

Amarin Jumps After Diabetes Association Adds Drug to Its 'Must Have' List

Amarin Jumps After Diabetes Association Adds Drug to Its 'Must Have' List

The American Diabetes Association adds Amarin's Vascepa drug to its standard of care recommendation list.

Market Gains Some Momentum, Lululemon Breaks Out

Market Gains Some Momentum, Lululemon Breaks Out

While there is some positive movement, it has not been sustained which makes trading quite tricky.

The Market Worries About Global Growth but Looks for Progress on China Trade

The Market Worries About Global Growth but Looks for Progress on China Trade

China negotiations resume today and the potential for weekend news is high.

Alibaba and Amarin Among Unanimous Strong Buy Stocks

Alibaba and Amarin Among Unanimous Strong Buy Stocks

You know a stock is doing well when the all market's best analysts are bullish.

Lifshitz & Miller LLP Announces Investigation Of Amarin Corporation Plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., And The Kraft Heinz Company

Lifshitz & Miller LLP Announces Investigation Of Amarin Corporation Plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., And The Kraft Heinz Company

NEW YORK, March 22, 2019 /PRNewswire/ -- Amarin Corporation plc (AMRN) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Amarin administered an active agent to their placebo group during...

AMARIN ALERT: Gibbs Law Group Has Filed Sole Class Action; Shareholders Should Contact The Firm About Their Rights

AMARIN ALERT: Gibbs Law Group Has Filed Sole Class Action; Shareholders Should Contact The Firm About Their Rights

Gibbs Law Group filed the only class action lawsuit to date against Amarin Corporation (NASDAQ: AMRN).

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm

NEW YORK, March 15, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amarin Corporation ("Amarin" or the "Company")(NASDAQ:AMRN) of the April 23, 2019 deadline to seek the role of lead plaintiff in a...

Robbins Arroyo LLP: Amarin Corporation Plc (AMRN) Sued For Misleading Shareholders

Robbins Arroyo LLP: Amarin Corporation Plc (AMRN) Sued For Misleading Shareholders

Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Amarin Corporation plc (NASDAQ: AMRN) filed a class action complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between September 24,...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amarin Corporation ("Amarin" or the "Company") (NASDAQ:AMRN) of the April 23, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has...

Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against Amarin Corporation Plc (AMRN)

Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against Amarin Corporation Plc (AMRN)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the April 23, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Amarin Corporation plc ("Amarin" or the "Company") (NASDAQ: AMRN)...

AMARIN INVESTOR ALERT: Gibbs Law Group Has Filed Sole Class Action; Shareholders Should Contact The Firm About Their Rights

AMARIN INVESTOR ALERT: Gibbs Law Group Has Filed Sole Class Action; Shareholders Should Contact The Firm About Their Rights

Gibbs Law Group filed the only class action lawsuit to date against Amarin Corporation (NASDAQ: AMRN).

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Amarin Corporation Plc And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Amarin Corporation Plc And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amarin Corporation plc ("Amarin" or "the Company") (NASDAQ: AMRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Amarin Corporation Plc And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Amarin Corporation Plc And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amarin Corporation plc ("Amarin" or "the Company") (NASDAQ: AMRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Amarin Corporation Plc - AMRN

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Amarin Corporation Plc - AMRN

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) from September 24, 2018 through November 9, 2018, inclusive (the "Class...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Amarin Corporation Plc - AMRN

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Amarin Corporation Plc - AMRN

NEW YORK, Feb. 25, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amarin Corporation plc ("Amarin" or the "Company") (NASDAQ: AMRN).

AMARIN CORPORATION INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit Alleging Violations Of Federal Securities Laws

AMARIN CORPORATION INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit Alleging Violations Of Federal Securities Laws

Gibbs Law Group announces that it has filed a class action lawsuit against Amarin Corporation (NASDAQ: AMRN) and certain of its officers and directors.

What Will Warren Buffett Say About Kraft Heinz?

What Will Warren Buffett Say About Kraft Heinz?

So far there is no bounce in Kraft Heinz which is not a good sign.

Trading Notes for Select Stocks

Trading Notes for Select Stocks

Here's my take on a list of stocks I've been watching.

Facebook Is Today's Star as Pockets of Strong Momentum Grow

Facebook Is Today's Star as Pockets of Strong Momentum Grow

It is the action in secondary stocks that is giving the action a much better feel.

Pfizer and the Urge to Merge

Pfizer and the Urge to Merge

My stated reason for being in Pfizer all along has been price stability and income.

This Market May Just Be in an Uptrend: Market Recon

This Market May Just Be in an Uptrend: Market Recon

This is the kind of reversal that happens in a bull market.

Gridlock and Economic Slowing: Cramer's 'Mad Money' Recap (Tuesday 11/6/18)

Gridlock and Economic Slowing: Cramer's 'Mad Money' Recap (Tuesday 11/6/18)

Jim Cramer explains his post-election play book: Growth stocks may be the way to go.

Canada Goose, Celgene, BlackRock: 'Mad Money' Lightning Round

Canada Goose, Celgene, BlackRock: 'Mad Money' Lightning Round

Jim Cramer weighs in on Canada Goose, Celgene, BlackRock, Nio, Hospitality Property Trust, Activision Blizzard and more.

TheStreet Quant Rating: D (Sell)